Vancouver - (NewMediaWire) - February 12, 2021 - Neovasc Inc. (Neovasc or the Company) (Nasdaq: NVCN / TSX: NVCN) announced today that it has closed its previously announced sale of an aggregate of 36,000,000 common shares at a purchase price of US$2.00 per common share...
Read MoreVancouver - (NewMediaWire) - February 10, 2021 - Neovasc Inc. (Neovasc or the Company) (NASDAQ: NVCN / TSX: NVCN) announced today that it has entered into definitive agreements with certain healthcare-focused institutional investors for the sale of an aggregate of 36,000,000 common shares at a...
Read MoreVancouver and Minneapolis - (NewMediaWire) - February 09, 2021 - Neovasc, Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN) announced today that it has received written notification from the Nasdaq Stock Market LLC (Nasdaq) notifying the Company that it has regained compliance with the minimum...
Read MoreVANCOUVER and MINNEAPOLIS - (NewMediaWire) - February 05, 2021 - Neovasc, Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN) today announced that the Journal of the American Heart Association has published an article entitled Angina Severity, Mortality, and Healthcare Utilization Among Veterans with Stable Angina....
Read MoreVANCOUVER and MINNEAPOLIS, MN - (NewMediaWire) - February 2, 2021 - Neovasc, Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN) today announced that theGerman Institute for the Hospital Remuneration System ("InEK") has awarded the Neovasc Reducer™ ("Reducer"), a CE-Marked medical device for the treatment of...
Read MoreVANCOUVER and MINNEAPOLIS - (NewMediaWire) - January 29, 2021 - Neovasc, Inc.("Neovasc" or the "Company") (NASDAQ, TSX: NVCN) announced today that the American Medical Association (AMA) has issued a new Current Procedural Terminology (CPT(R)) Category III Code fortranscatheter implantation of a coronary sinus reduction device....
Read MoreVANCOUVER and MINNEAPOLIS - (NewMediaWire) - January 19, 2021 - Neovasc Inc. (Neovasc or the Company) (Nasdaq, TSX: NVCN) announced today the Neovasc Reducer™ (Reducer) was prominently featured in three peer reviewed European Journals. Management of refractory angina: an update(1) was published in the European Heart...
Read MoreVANCOUVER and MINNEAPOLIS - (NewMediaWire) - January 15, 2021 - Neovasc Inc. (Neovasc or the Company) ( Nasdaq, TSX : NVCN) announced today that it has received a not-approvable letter from U.S. Food & Drug Administration (FDA) regarding its PMA submission for the Neovasc...
Read More